Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
Clinical trial NCT02180165 · COMPLETED
Trial details
- NCT number
- NCT02180165
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-29
- Primary completion
- 2018-01-24
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.